BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,195,693 | +77.6% | 592,612 | +76.6% | 0.10% | +69.4% |
| Q2 2023 | $2,362,047 | +143.4% | 335,518 | +188.3% | 0.06% | +129.6% |
| Q1 2023 | $970,526 | -60.9% | 116,370 | -46.2% | 0.03% | -61.4% |
| Q4 2022 | $2,482,665 | +85.0% | 216,260 | +103.1% | 0.07% | +48.9% |
| Q3 2022 | $1,342,000 | +72.5% | 106,470 | +44.8% | 0.05% | +34.3% |
| Q2 2022 | $778,000 | -20.4% | 73,512 | +22.2% | 0.04% | -23.9% |
| Q1 2022 | $978,000 | +437.4% | 60,153 | +376.2% | 0.05% | +228.6% |
| Q3 2021 | $182,000 | -42.8% | 12,632 | -37.1% | 0.01% | -48.1% |
| Q2 2021 | $318,000 | +48.6% | 20,083 | -47.7% | 0.03% | -54.2% |
| Q2 2017 | $214,000 | -49.9% | 38,432 | -24.3% | 0.06% | +7.3% |
| Q1 2017 | $427,000 | +84.8% | 50,791 | +39.3% | 0.06% | +48.6% |
| Q4 2016 | $231,000 | -63.3% | 36,458 | -34.0% | 0.04% | -31.5% |
| Q3 2015 | $630,000 | -66.6% | 55,279 | -56.2% | 0.05% | -74.5% |
| Q2 2015 | $1,885,000 | +824.0% | 126,300 | +456.4% | 0.21% | +909.5% |
| Q1 2015 | $204,000 | – | 22,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |